BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Mao C, Zhao Y, Li F, Li Z, Tian S, Debinski W, Ming X. P-glycoprotein targeted and near-infrared light-guided depletion of chemoresistant tumors. J Control Release 2018;286:289-300. [PMID: 30081143 DOI: 10.1016/j.jconrel.2018.08.005] [Cited by in Crossref: 13] [Cited by in F6Publishing: 16] [Article Influence: 2.6] [Reference Citation Analysis]
Number Citing Articles
1 Wei D, Qi J, Hamblin MR, Wen X, Jiang X, Yang H. Near-infrared photoimmunotherapy: design and potential applications for cancer treatment and beyond. Theranostics 2022;12:7108-31. [PMID: 36276636 DOI: 10.7150/thno.74820] [Reference Citation Analysis]
2 Li F, Mao C, Yeh S, Xin J, Wang P, Shi Q, Ming X. Combinatory therapy of MRP1-targeted photoimmunotherapy and liposomal doxorubicin promotes the antitumor effect for chemoresistant small cell lung cancer. Int J Pharm 2022;625:122076. [PMID: 35931394 DOI: 10.1016/j.ijpharm.2022.122076] [Reference Citation Analysis]
3 Nakajima K, Miyazaki F, Terada K, Takakura H, Suzuki M, Ogawa M. Comparison of low-molecular-weight ligand and whole antibody in prostate-specific membrane antigen targeted near-infrared photoimmunotherapy. Int J Pharm 2021;609:121135. [PMID: 34571072 DOI: 10.1016/j.ijpharm.2021.121135] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
4 Liang BJ, Lusvarghi S, Ambudkar SV, Huang H. Use of photoimmunoconjugates to characterize ABCB1 in cancer cells. Nanophotonics 2021;10:3049-3061. [DOI: 10.1515/nanoph-2021-0252] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
5 Perrotti V, Caponio VCA, Mascitti M, Lo Muzio L, Piattelli A, Rubini C, Capone E, Sala G. Therapeutic Potential of Antibody-Drug Conjugate-Based Therapy in Head and Neck Cancer: A Systematic Review. Cancers (Basel) 2021;13:3126. [PMID: 34206707 DOI: 10.3390/cancers13133126] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
6 Li F, Mao C, Yeh S, Sun Y, Xin J, Shi Q, Ming X. MRP1-targeted near infrared photoimmunotherapy for drug resistant small cell lung cancer. Int J Pharm 2021;604:120760. [PMID: 34077781 DOI: 10.1016/j.ijpharm.2021.120760] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
7 Gerard L, Duvivier L, Gillet JP. Targeting tumor resistance mechanisms. Fac Rev 2021;10:6. [PMID: 33659924 DOI: 10.12703/r/10-6] [Reference Citation Analysis]
8 Wang Z, Meng Q, Li S. The Role of NIR Fluorescence in MDR Cancer Treatment: From Targeted Imaging to Phototherapy. Curr Med Chem 2020;27:5510-29. [PMID: 31244415 DOI: 10.2174/0929867326666190627123719] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
9 Gomez S, Tsung A, Hu Z. Current Targets and Bioconjugation Strategies in Photodynamic Diagnosis and Therapy of Cancer. Molecules 2020;25:E4964. [PMID: 33121022 DOI: 10.3390/molecules25214964] [Cited by in Crossref: 8] [Cited by in F6Publishing: 11] [Article Influence: 2.7] [Reference Citation Analysis]
10 Qi T, Shi Y, Huang Y, Fu X, Qiu S, Sun Q, Lin G. The role of antibody delivery formation in cancer therapy. J Drug Target 2020;28:574-84. [PMID: 32037905 DOI: 10.1080/1061186X.2020.1728537] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
11 Niu X, Cao J, Zhang Y, Gao X, Cheng M, Liu Y, Wang W, Yuan Z. A glutathione responsive nitric oxide release system based on charge-reversal chitosan nanoparticles for enhancing synergistic effect against multidrug resistance tumor. Nanomedicine: Nanotechnology, Biology and Medicine 2019;20:102015. [DOI: 10.1016/j.nano.2019.102015] [Cited by in Crossref: 17] [Cited by in F6Publishing: 13] [Article Influence: 4.3] [Reference Citation Analysis]
12 Fernandes SRG, Fernandes R, Sarmento B, Pereira PMR, Tomé JPC. Photoimmunoconjugates: novel synthetic strategies to target and treat cancer by photodynamic therapy. Org Biomol Chem 2019;17:2579-93. [PMID: 30648722 DOI: 10.1039/c8ob02902d] [Cited by in Crossref: 35] [Cited by in F6Publishing: 36] [Article Influence: 8.8] [Reference Citation Analysis]
13 Mao C, Qu P, Miley MJ, Zhao Y, Li Z, Ming X. P-glycoprotein targeted photodynamic therapy of chemoresistant tumors using recombinant Fab fragment conjugates. Biomater Sci 2018;6:3063-74. [PMID: 30298866 DOI: 10.1039/c8bm00844b] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 2.5] [Reference Citation Analysis]
14 Wei G, Huang L, Jiang Y, Shen Y, Huang Z, Huang Y, Sun X, Zhao C. Lenvatinib-zinc phthalocyanine conjugates as potential agents for enhancing synergistic therapy of multidrug-resistant cancer by glutathione depletion. European Journal of Medicinal Chemistry 2019;169:53-64. [DOI: 10.1016/j.ejmech.2019.02.065] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 3.3] [Reference Citation Analysis]
15 Mao C, Li F, Zhao Y, Debinski W, Ming X. P-glycoprotein-targeted photodynamic therapy boosts cancer nanomedicine by priming tumor microenvironment. Theranostics 2018;8:6274-90. [PMID: 30613297 DOI: 10.7150/thno.29580] [Cited by in Crossref: 23] [Cited by in F6Publishing: 26] [Article Influence: 4.6] [Reference Citation Analysis]
16 Suo X, Eldridge BN, Zhang H, Mao C, Min Y, Sun Y, Singh R, Ming X. P-Glycoprotein-Targeted Photothermal Therapy of Drug-Resistant Cancer Cells Using Antibody-Conjugated Carbon Nanotubes. ACS Appl Mater Interfaces 2018;10:33464-73. [PMID: 30188117 DOI: 10.1021/acsami.8b11974] [Cited by in Crossref: 39] [Cited by in F6Publishing: 41] [Article Influence: 7.8] [Reference Citation Analysis]